The drug ADLYXIN contains
one active pharmaceutical ingredient (API):
UNII 74O62BB01U - LIXISENATIDE
Lixisenatide is a selective GLP-1 receptor agonist. The GLP-1 receptor is the target for native GLP-1, an endogenous incretin hormone that potentiates glucose-dependent insulin secretion from the pancreatic beta cells.
Read about Lixisenatide
This drug has been assigned below unique identifiers within the countries it is being marketed: